Biogen Inc (NASDAQ:BIIB)

236.63
Delayed Data
As of Sep 13
 +4.32 / +1.86%
Today’s Change
215.78
Today|||52-Week Range
358.41
-21.36%
Year-to-Date
What September Doldrums? Here's Why Stocks Are Moving Higher
Sep 13 / Zacks.com - Paid Partner Content
5 Price-to-Book Value Picks for September
Sep 05 / Zacks.com - Paid Partner Content
Top 5 ROE Stocks to Profit as Sino-US Trade Tensions Abate
Sep 13 / Zacks.com - Paid Partner Content
Novartis Inks Commercialization Deal for Tysabri Biosimilar
Sep 04 / Zacks.com - Paid Partner Content
Amgen's KRAS Inhibitor Shows Response in Larger NSCLC Group
Sep 09 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close232.31
Today’s open232.00
Day’s range232.00 - 237.98
Volume1,688,983
Average volume (3 months)1,516,797
Market cap$43.6B
Data as of 4:00pm ET, 09/13/2019

Growth & Valuation

Earnings growth (last year)+81.10%
Earnings growth (this year)+23.05%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+9.67%
P/E ratio8.8
Price/Sales5.13
Price/Book3.58

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+3.39+1.14%
EXASExact Sciences Corp-1.98-1.82%
BMRNBiomarin Pharmaceuti...-0.15-0.21%
NBIXNeurocrine Bioscienc...+2.28+2.42%
Data as of 4:00pm ET, 09/13/2019

Financials

Next reporting dateOctober 22, 2019
EPS forecast (this quarter)$8.23
Annual revenue (last year)$12.1B
Annual profit (last year)$4.4B
Net profit margin36.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Chief Financial Officer &
Executive Vice President
Jeffrey D. Capello
Corporate headquarters
Cambridge, Massachusetts

Forecasts